The "possibility of abuse," a warning phrase for narcotic painkillers containing Tapentadol, will be deleted. The permit includes a new disorder of resistance and opioid use, and monitoring and addiction patients consider consulting with experts. The Ministry of Food and Drug Safety announced that it will prepare a proposal for a change in permission based on the results of the European Medicines Agency's (EMA) review of safety information on tapentadol oral drugs and conduct an opinion inquiry by the 9th of next month. Tapentadol licensed in Korea are 6 items, including 50mg, 100mg, 150mg of "Nucynta" by Janssen Korea, 50mg of "Nucynta ER", 100mg, and 150mg. Tapentadol, the main active ingredient of Nucynta, is chara